Physician profile
Arpit Chhabra
NPI 1396006599
$97,232.19
in general payments reported to CMS, 2019-2025
11 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $1,511 · 2021: $4,024 · 2022: $13K · 2023: $22K · 2024: $21K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $67K · Travel and Lodging: $9,073 · Food and Beverage: $2,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $66,781.84 |
| Travel and Lodging | $9,073.32 |
| Food and Beverage | $2,508.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $96,113.84 | 2020-2025 | Icotec Blackarmor Spine System, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Raysearch Laboratories Ab (Publ) | $485.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $302.54 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $141.93 | 2019 | |
| Ion Beam Applications S.A. | $51.00 | 2019 | |
| Teleflex LLC | $35.18 | 2024 | |
| Myovant Sciences INC. | $32.38 | 2021 | |
| Varian Medical Systems, INC. | $20.28 | 2019 | |
| Sumitomo Pharma America, INC. | $19.68 | 2023 | Orgovyx |
| Iba Proton Therapy, INC. | $19.23 | 2024 | |
| Angiodynamics, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpit Chhabra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.